SecSonar.com

Progyny, Inc. (PGNY)

Progyny, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Progyny, Inc. (PGNY) is a Medical - Healthcare Information Services company based in US with a market capitalization of $2B. Revenue grew 10.4% year-over-year and the company generated $191.8M in free cash flow. This page tracks PGNY's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 675 employees · IPO Oct 25, 2019

Valuation

Valuation & price

$23.25 · as of May 17, 2026 · -18.4% vs 52w high

35.5

P/E ratio

Latest-FY diluted EPS

3.93

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$28.47$22.50$16.53Jul 25Dec 25Jun 26Jul 7, 25$21.45Jul 9, 25$23.78Jul 11, 25$23.21Jul 15, 25$23.24Jul 17, 25$23.01Jul 21, 25$22.94Jul 23, 25$23.46Jul 25, 25$23.11Jul 29, 25$22.83Jul 31, 25$23.51Aug 4, 25$23.18Aug 6, 25$23.49Aug 8, 25$22.85Aug 12, 25$21.78Aug 14, 25$22.55Aug 18, 25$23.78Aug 20, 25$22.56Aug 22, 25$23.53Aug 27, 25$23.02Aug 29, 25$23.67Sep 3, 25$23.54Sep 5, 25$22.55Sep 9, 25$22.97Sep 11, 25$23.17Sep 15, 25$22.13Sep 17, 25$21.63Sep 19, 25$21.62Sep 23, 25$21.47Sep 25, 25$21.36Sep 29, 25$21.42Oct 1, 25$21.22Oct 3, 25$20.59Oct 7, 25$20.00Oct 9, 25$20.57Oct 13, 25$20.43Oct 16, 25$21.33Oct 20, 25$19.63Oct 22, 25$19.17Oct 24, 25$19.49Oct 28, 25$19.23Oct 30, 25$18.65Nov 3, 25$18.43Nov 5, 25$18.88Nov 7, 25$22.37Nov 11, 25$23.81Nov 13, 25$24.42Nov 17, 25$26.82Nov 19, 25$25.40Nov 21, 25$25.86Nov 25, 25$26.77Nov 28, 25$26.37Dec 2, 25$24.95Dec 5, 25$24.02Dec 9, 25$24.72Dec 11, 25$26.01Dec 15, 25$26.34Dec 17, 25$25.99Dec 19, 25$26.63Dec 23, 25$25.57Dec 26, 25$25.80Dec 30, 25$25.84Jan 2, 26$25.74Jan 6, 26$26.67Jan 8, 26$27.43Jan 12, 26$28.42Jan 14, 26$26.12Jan 16, 26$24.52Jan 21, 26$25.45Jan 23, 26$25.22Jan 28, 26$24.53Jan 30, 26$23.87Feb 3, 26$23.24Feb 5, 26$21.92Feb 9, 26$21.65Feb 11, 26$21.55Feb 13, 26$20.69Feb 18, 26$20.36Feb 20, 26$20.98Feb 24, 26$20.78Feb 26, 26$22.25Mar 2, 26$17.60Mar 4, 26$17.79Mar 6, 26$18.31Mar 10, 26$17.91Mar 12, 26$17.50Mar 16, 26$17.42Mar 19, 26$18.18Mar 23, 26$18.01Mar 25, 26$17.75Mar 27, 26$17.27Mar 31, 26$16.98Apr 2, 26$16.60Apr 7, 26$17.16Apr 9, 26$16.53Apr 13, 26$16.98Apr 15, 26$17.39Apr 17, 26$18.12Apr 21, 26$18.02Apr 23, 26$17.67Apr 27, 26$18.41Apr 29, 26$18.42May 1, 26$18.60May 5, 26$18.98May 8, 26$23.72May 12, 26$23.45May 14, 26$22.87May 18, 26$24.05May 20, 26$25.64May 22, 26$24.88May 27, 26$25.48May 29, 26$25.56Jun 2, 26$25.12Jun 4, 26$25.48Jun 8, 26$25.92Jun 10, 26$25.89Jun 12, 26$26.63Jun 16, 26$26.60Jun 18, 26$26.08Jun 23, 26$26.63Jun 29, 26$28.47
$16.3052-week range$28.51
Loading valuation history…

Fundamentals

Key fundamentals

$2B

Market cap

10.4%

Revenue growth (YoY)

23.6%

Gross margin

$191.8M

Free cash flow (USD)

-$286.1M

Net debt

Net cash position

-6.8%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$48.6MFY 2018$105.4MFY 2019$229.7MFY 2020$344.9MFY 2021$500.6MFY 2022$786.9MFY 2023$1.1BFY 2024$1.2BFY 2025$1.3B
$48.6M$1.3B

Free cash flow by year

2017 → 2025

FY 2017$-10.1MFY 2018$1.7MFY 2019$-4.5MFY 2020$35.2MFY 2021$23.9MFY 2022$77.2MFY 2023$185.2MFY 2024$173.7MFY 2025$191.8M
-$10.1M$191.8M

Gross margin by year

2021 → 2025

FY 202122.4%FY 202221.3%FY 202321.9%FY 202421.7%FY 202523.6%
22.4%23.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventBylaw AmendmentsMay 27, 2026Filing
  • 8-K eventShare RepurchaseMay 26, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing

Questions

Frequently asked questions

What is Progyny, Inc.'s market cap?

Progyny, Inc. (PGNY) has a market capitalization of $2B.

What is PGNY's P/E ratio?

PGNY trades at a price-to-earnings ratio of 35.5, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is PGNY's price-to-book (P/B) ratio?

PGNY trades at 3.93 times book value per share.

Are insiders buying PGNY stock?

SEC Form 4 filings show no open-market insider buys at Progyny, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Healthcare Information Services

OMCL

Omnicell, Inc.

$2B

WGS

GeneDx Holdings Corp.

$1.5B

TDOC

Teladoc Health, Inc.

$1.4B

PRVA

Privia Health Group, Inc.

$2.7B

HTFL

Heartflow, Inc. Common Stock

$2.7B

SDGR

Schrödinger, Inc.

$1.1B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.